Evaxion Biotech A/S expected to post a loss of 19 cents a share - Earnings Preview

Evaxion A/S

04/12/2023 13:42

* Evaxion Biotech A/S  EVAX.OQ   EVAX.O  is expected to show
no
change in quarterly revenue when it reports  results  for the
period ending June 30 2023
    * 
    * ​LSEG's mean analyst estimate for Evaxion Biotech A/S is
for a
loss of 19 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Evaxion
Biotech
A/S is $7.00​, above​ its last closing price of $0.82. ​​​

This summary was machine generated December 4 at 13:42 GMT.  All
figures in US dollars unless otherwise stated